Reneuron Group Competitors and Similar CompaniesClear all

Reneuron Group's competitors and similar companies include Blueprint Genetics, Tessera Therapeutics, Poseida Therapeutics and Shanghai Fudan-Zhangjiang Bio-Pharmaceutical.

	Reneuron Group ReNeuron Group engages in R&D and the commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications.	Blueprint Genetics Blueprint Genetics provides clinical gene testing and customized next-generation sequencing services.	Tessera Therapeutics Tessera Therapeutics is a biotechnology company specializing in genetic medicine.	Poseida Therapeutics Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics.	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is a company that manufactures biomedicine.
Founding Date	Founding Date 1997	Founding Date 2012	Founding Date 2018	Founding Date 2015	Founding Date 1996
Type	Type Public	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics
Locations	Locations Pencoed, GB HQ	Locations Esbo, FI HQ Dubai, AE Seattle, US	Locations Cambridge, US HQ	Locations San Diego, US HQ	Locations CN HQ
Employees	Employees 5320% increase	Employees 2191% decrease	Employees 3472% increase	Employees 3111% decrease	Employees 921
Financial
Revenue (est.)	Revenue (est.) £849k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $64.7m (FY, 2023)	Revenue (est.) N/A
Net income	Net income £782k (FY, 2025)	Net income N/A	Net income N/A	Net income ($123.4m) (FY, 2023)	Net income N/A
Funding
Total funding raised	Total funding raised $ 38.4m	Total funding raised $ 26.3m	Total funding raised N/A	Total funding raised $ 336.5m	Total funding raised N/A